Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

If tariffs are put in place, it will be a big change for the industry. A 1994 World Trade Organization agreement eliminated levies on a whole swath of pharmaceutical products and the substances used to make them. This gave rise to companies pursuing a host of business strategies aimed at lowering tax rates. "This is largely due to low tax rates in these countries," Wells Fargo analyst Mohit Bansal said. "These companies pay lower overall taxes due to these manufacturing operations and oftentimes [intellectu ...